Citi analyst Jason Cassorla maintained a Hold rating on InnovAge Holding (INNV – Research Report) yesterday and set a price target of $7.00. The company’s shares closed yesterday at $6.50.
According to TipRanks, Cassorla is an analyst with an average return of -19.1% and a 30.23% success rate. Cassorla covers the Healthcare sector, focusing on stocks such as Community Health, Tenet Healthcare, and Cano Health.
The word on The Street in general, suggests a Hold analyst consensus rating for InnovAge Holding with a $7.00 average price target.
See the top stocks recommended by analysts >>
INNV market cap is currently $881.6M and has a P/E ratio of -20.81.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes.
Read More on INNV:
- InnovAge Announces Financial Results For the Fourth Quarter and Fiscal Year Ended June 30, 2023
- INNV Upcoming Earnings Report: What to Expect?
- InnovAge to Announce Fiscal Fourth Quarter 2023 Financial Results and Host Conference Call Tuesday, September 12, 2023
- InnovAge appoints Sparks to its board of directors
- InnovAge Strengthens Board with Appointment of New Independent Director
